SCNI Scinai Immunotherapeutics Ltd.
-
Scinai Immunotherapeutics Reported Earnings
Wednesday, June 10, 2026 · 12:00 AM ET
Scinai Immunotherapeutics (SCNI) reported earnings of $0.94 per share on revenue of $0.49 million for the . .
Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing inflammation and immunology biological products primarily for the treatment of autoimmune and infectious diseases. Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals Ltd., is based in JERUSALEM.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
$0.94
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth—
Reported Revenue
$0.49M
Revenue Estimate
—
Revenue Surprise
Revenue Growth—